CRI Worldwide, LLC

Marlton, New Jersey 08053

0 studies enrolling now · 9 studies all time

What they study most

Chronic Hepatitis C Virus, Cognitive Dysfunction, Cognitive Impairment Associated With Schizophrenia (CIAS), Idiopathic Parkinson's Disease, Low Back Pain, Major Depressive Disorder, Negative Symptoms, Parkinson Disease, Schizophrenia, Smoking Cessation

Studies at this site

• PF-06669571 In Subjects With Idiopathic Parkinson's Disease — Completed
• Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Velpatasvir in Participants With Chronic HCV Infection — Completed
• Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations — Stopped early
• A Phase 3 Study of Tanezumab for Chronic Low Back Pain — Completed
• A Study To Evaluate The Safety And Efficacy Of PF-04958242 In Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS) — Stopped early
• Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders. — Completed
• Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia — Completed
• A Study To Evaluate The Efficacy And Safety Of Varenicline Compared To Placebo For Smoking Cessation Through Reduction — Completed
• Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD) — Completed